Gurley WQ - Search Results

1

Ultrasound-guided femoral vein catheterization in neonates with cardiac disease*.

Alten JA, Borasino S, Gurley WQ, Law MA, Toms R, Dabal RJ. Alten JA, et al. Among authors: gurley wq. Pediatr Crit Care Med. 2012 Nov;13(6):654-9. doi: 10.1097/PCC.0b013e318250af0c. Pediatr Crit Care Med. 2012. PMID: 22791091

2

The hemostatic history of a 15-month-old child implanted with a Berlin heart left ventricular assist device.

Steenwyk BL, Kirklin JK, Gurley WQ, Nielsen VG. Steenwyk BL, et al. Among authors: gurley wq. Anesth Analg. 2007 Mar;104(3):538-40. doi: 10.1213/01.ane.0000255155.87860.94. Anesth Analg. 2007. PMID: 17312204

3

Decreasing the Preincision Time for Pulmonary Lobectomy: The Process of Lean and Value Stream Mapping.

Cerfolio RJ, Steenwyk BL, Watson C, Sparrow J, Belopolsky V, Townsley M, Lyerly R, Downing M, Bryant A, Gurley WQ, Henling C, Crawford J, Gayeski TE. Cerfolio RJ, et al. Among authors: gurley wq. Ann Thorac Surg. 2016 Mar;101(3):1110-5. doi: 10.1016/j.athoracsur.2015.09.004. Epub 2015 Nov 19. Ann Thorac Surg. 2016. PMID: 26602005

4

The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography.

Nielsen VG, Gurley WQ Jr, Burch TM. Nielsen VG, et al. Among authors: gurley wq jr. Anesth Analg. 2004 Jul;99(1):120-123. doi: 10.1213/01.ANE.0000123012.24871.62. Anesth Analg. 2004. PMID: 15281516

5

The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation.

Nielsen VG, Lyerly RT 3rd, Gurley WQ. Nielsen VG, et al. Among authors: gurley wq. Anesth Analg. 2004 Dec;99(6):1587-1592. doi: 10.1213/01.ANE.0000136843.58799.AB. Anesth Analg. 2004. PMID: 15562037

6

Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.

Nielsen VG, Steenwyk BL, Gurley WQ. Nielsen VG, et al. Among authors: gurley wq. J Heart Lung Transplant. 2006 Oct;25(10):1247-52. doi: 10.1016/j.healun.2006.06.009. J Heart Lung Transplant. 2006. PMID: 17045938

7

Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.

Nielsen VG, Steenwyk BL, Gurley WQ, Pereira SJ, Lell WA, Kirklin JK. Nielsen VG, et al. Among authors: gurley wq. J Heart Lung Transplant. 2006 Jun;25(6):653-63. doi: 10.1016/j.healun.2006.02.010. Epub 2006 May 2. J Heart Lung Transplant. 2006. PMID: 16730571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters